CJC-1295 5mg (No DAC) + Ipamorelin 5mg

Explore advanced growth hormone signaling research with the CJC-1295 (No DAC) + Ipamorelin Blend from Okie Peps. Designed for controlled laboratory investigation, this convenient 10mg dual-peptide blend combines 5mg of CJC-1295 without DAC and 5mg of Ipamorelin in a precise 1:1 formulation.

This blend provides researchers with an opportunity to investigate two complementary pathways involved in growth hormone (GH) signaling. CJC-1295 without DAC is a growth hormone-releasing hormone (GHRH) analogue, while Ipamorelin is a selective growth hormone secretagogue studied for its activity at the growth hormone secretagogue receptor (GHSR-1a).

By combining these compounds, researchers can investigate the interaction between GHRH and GHSR signaling, including downstream growth hormone release, endocrine signaling, metabolic pathways, and related cellular responses.

CJC-1295 without DAC is specifically suited for research involving shorter-duration GHRH signaling compared with long-acting DAC-conjugated analogues. Ipamorelin provides a complementary pathway through selective GHSR activation, making the combination useful for experimental models examining coordinated GH-related signaling.

At Okie Peps, quality and transparency are at the center of what we do. CJC-1295 + Ipamorelin is supplied as a white to off-white lyophilized powder to support stability, consistency, and convenient laboratory handling. Product-specific purity, testing methodology, and supporting documentation should be verified through the applicable Certificate of Analysis (COA).

Research Potential & Investigated Pathways

GHRH & GHSR Signaling
Provides a dual-pathway research model for examining the interaction between GHRH receptor signaling from CJC-1295 and GHSR-1a activation from Ipamorelin.

Growth Hormone Signaling
Investigated for the combined effects of two distinct peptide pathways associated with growth hormone release and downstream endocrine activity.

Selective GHSR-1a Activation
Ipamorelin is studied as a selective growth hormone secretagogue, providing researchers with a tool for investigating GHSR-mediated signaling.

GHRH Research
CJC-1295 without DAC is investigated for its interaction with GHRH receptors and subsequent pituitary growth hormone signaling.

Metabolic & Cellular Research
The blend may be used in controlled experimental models examining relationships between GH-related signaling, metabolism, cellular activity, and body-composition pathways.

Storage & Stability

Before Reconstitution: Store lyophilized powder according to the storage conditions provided with the product or its Certificate of Analysis. Protect from excessive heat, moisture, and direct light.

After Reconstitution: Follow appropriate laboratory storage procedures and product-specific documentation. Avoid repeated freeze-thaw cycles.

Handling & Disclaimer

• FOR LABORATORY RESEARCH USE ONLY.
• NOT FOR HUMAN CONSUMPTION.
• Not intended for medical, diagnostic, therapeutic, or veterinary use.
• To be handled exclusively by qualified professionals in controlled laboratory settings.

Product Specifications

Product Name: CJC-1295 (No DAC) + Ipamorelin
Brand: Okie Peps
CJC-1295 (No DAC): 5mg
Ipamorelin (IPA): 5mg
Total Quantity per Vial: 10mg
Blend Ratio: 1:1
Formulation Type: Dual-Peptide Research Blend
Research Focus: GHRH signaling, GHSR-1a activation, growth hormone and endocrine pathways
Form: Lyophilized powder
Appearance: White to off-white powder
Intended Use: Laboratory Research Only